1
Registered trials
0
Recruiting
1
Unique sponsors
1
Unique IMPs
0
Commercial trials
Drug classes (ATC)
—
ATC code not specified
1
Mechanism of action (INN-stem analysis)
GLP-1 receptor agonist
1 substance
Phase IV:
1
Phase IV
1 trial-
EndedRijnstate Ziekenhuis Stichting AcademicSEMAGLUTIDE
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Rijnstate Ziekenhuis Stichting | Academic | 1 | Phase IV | 0 |
New trials by year
2024
1